NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)
$40.52 -0.41 (-1.0017%)
Analysed NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) News Sources
Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade
17-04-2026
yahoo.com
Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied.
17-04-2026
yahoo.com
Novo Nordisk’s Wegovy Wins EMA Flexibility In GLP-1 Access Push
17-04-2026
yahoo.com
LLY's Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes Study
17-04-2026
yahoo.com
China Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and Sanofi
17-04-2026
yahoo.com
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
17-04-2026
marketbeat.com
Eli Lilly Weight-Loss Pill Prescriptions Near 1,400 in First Week
17-04-2026
yahoo.com
Lilly's Foundayo hits 1,390 prescriptions in debut week
17-04-2026
yahoo.com
Multinational giants step up presence in north China's tech zone TEDA
17-04-2026
yahoo.com
Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
17-04-2026
biopharmadive.com
What is the current price of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)?
The current price of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) is $40.52.
NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) absolute price change since previous trading day?
The absolute price change of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) since the previous trading day is $-0.41.
NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) percentage price change since previous trading day?
The percentage price change of NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) since the previous trading day is -1.0017%.
What is the most recent average sentiment score for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)?
The most recent average sentiment score for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) is 57 out of 100.
What is the most recent average sentiment for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)?
The most recent sentiment for NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE) is .
SEC-8K** Filing Available For NOVO-NORDISK A/S-SPONS ADR (NVO:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.